X0306 4 2019-03-28 1 0001624899 STERIS plc STE 0001235611 TOKICH MICHAEL J C/O RUTHERFORD HOUSE, STEPHENSONS WAY CHADDESDEN DERBY X0 DE21 6LY UNITED KINGDOM 0 1 0 0 Sr. Vice Pres., CFO Ordinary Shares, 10 pence par value 2019-03-28 4 D 0 50458 D 0 D Ordinary Shares, 10 pence par value 2019-03-28 4 D 0 3406 D 0 I See Footnote Below. Employee Stock Option (right to buy) 45.34 2019-03-28 4 D 0 22000 D 2023-05-31 Ordinary Shares 22000 0 D Employee Stock Option (right to buy) 53.52 2019-03-28 4 D 0 28000 D 2024-05-30 Ordinary Shares 28000 0 D Employee Stock Option (right to buy) 67.98 2019-03-28 4 D 0 20000 D 2025-08-10 Ordinary Shares 20000 0 D Employee Stock Option (right to buy) 69.72 2019-03-28 4 D 0 30000 D 2026-06-01 Ordinary Shares 30000 0 D Employee Stock Option (right to buy) 77.07 2019-03-28 4 D 0 32000 D 2027-05-30 Ordinary Shares 32000 0 D Employee Stock Option (right to buy) 114.22 2019-03-28 4 D 0 46664 D 2028-05-31 Ordinary Shares 46664 0 D 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-03-28